Momelotinib
![]() |
- ₹0
- Product name: Momelotinib
- CAS: 1056634-68-4
- MF: C23H22N6O2
- MW: 414.46
- EINECS:
- MDL Number:MFCD16038899
- Synonyms:CYT387, >=98%;CYT 11387;CYT 387;N-(Cyanomethyl)-4-[2-[[4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]benzamide;LM-1149;CYT 387(CYT 11387);N-(cyanoMethyl)-4-(2-(4-Morpholin-4-ylphenylaMino)pyriMidin-4-yl)benzaMide;MoMelotinib
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|
Properties
Density :1.292
storage temp. :Store at -20°C
solubility :insoluble in EtOH; insoluble in H2O; ≥20.7 mg/mL in DMSO
pka :10.94±0.46(Predicted)
form :Orange powder.
color :Light yellow to yellow
CAS DataBase Reference :1056634-68-4
storage temp. :Store at -20°C
solubility :insoluble in EtOH; insoluble in H2O; ≥20.7 mg/mL in DMSO
pka :10.94±0.46(Predicted)
form :Orange powder.
color :Light yellow to yellow
CAS DataBase Reference :1056634-68-4
Safety Information
Symbol(GHS): |
![]() |
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||
Hazard statements: |
|
||||||||||||||
Precautionary statements: |
|
Description
Momelotinib (CYT387) is an ATP-competitive inhibitor of JAK1/JAK2 with IC50 of 11 nM/18 nM, ~10-fold selectivity versus JAK3. Phase 3.Related product price
- Y27632 (hydrochloride)
₹14800-90886.7 - 935666-88-9
₹13875-55810.8 - Lestaurtinib
₹18380.85-73458.45